Impax Laboratories Inc. (IPXL)

17.90
0.22 1.24
NYSE : Health Technology
Prev Close 17.68
Open 17.72
Day Low/High 17.50 / 18.29
52 Wk Low/High 13.47 / 18.29
Volume 839.29K
Avg Volume 916.90K
Exchange NYSE
Shares Outstanding 73.87M
Market Cap 1.35B
EPS -6.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Insider Trading Alert - IPXL, TRC And SMED Traded By Insiders

Insider Trading Alert - IPXL, TRC And SMED Traded By Insiders

Stocks with insider trader activity include IPXL, TRC and SMED

Mylan Shareholders Back Proposal to Buy Perrigo

Mylan Shareholders Back Proposal to Buy Perrigo

Shareholders vote in favor of the proposed purchase as Perrigo continues to push back against the unsolicited offer.

Insider Trading Alert - IPXL, SFBS And SBSI Traded By Insiders

Insider Trading Alert - IPXL, SFBS And SBSI Traded By Insiders

Stocks with insider trader activity include IPXL, SFBS and SBSI

Specialty Pharma Firms That Could Be Potential Targets for Generics Giants

Specialty Pharma Firms That Could Be Potential Targets for Generics Giants

Companies are running out of acquisition targets and as a result, specialty pharma firms are now in the M&A spotlight as acquisitive drugmakers search for new ways to fuel growth.

Put Impax, Akorn and Sagent on Your Watch List of Generics Targets

Put Impax, Akorn and Sagent on Your Watch List of Generics Targets

If companies such as Teva and Perrigo continue to seek growth through acquisitions, they may gobble up Impax Laboratories, Akorn Pharmaceuticals or Sagent Pharmaceuticals.

Impax Laboratories (IPXL): Today's Weak On High Volume Stock

Impax Laboratories (IPXL): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a weak on high relative volume candidate

Today's Strong And Under The Radar Stock: Impax Laboratories (IPXL)

Today's Strong And Under The Radar Stock: Impax Laboratories (IPXL)

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a strong and under the radar candidate

Impax Laboratories (IPXL) Is Today's Strong And Under The Radar Stock

Impax Laboratories (IPXL) Is Today's Strong And Under The Radar Stock

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a strong and under the radar candidate

3 Mid-Cap Pharmaceutical Companies to Add to Your Portfolio

3 Mid-Cap Pharmaceutical Companies to Add to Your Portfolio

Pharmaceutical companies can be risky investments, yet some of these stocks do have upsides.

Quant Picks: 3 Mid-Cap Pharmaceutical Companies to Invest In

Quant Picks: 3 Mid-Cap Pharmaceutical Companies to Invest In

With Merck and Pfizer reporting earnings today, let's take a look at some of the best pharmaceutical companies TheStreet Quant Ratings says you should add to your portfolio right now.

New Lifetime High Reached: Impax Laboratories (IPXL)

New Lifetime High Reached: Impax Laboratories (IPXL)

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a new lifetime high candidate

Impax Laboratories (IPXL) Hits New Lifetime High

Impax Laboratories (IPXL) Hits New Lifetime High

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a new lifetime high candidate

Strong On High Volume: Impax Laboratories (IPXL)

Strong On High Volume: Impax Laboratories (IPXL)

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a strong on high relative volume candidate

New Lifetime High For Impax Laboratories (IPXL)

New Lifetime High For Impax Laboratories (IPXL)

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a new lifetime high candidate

Impax Laboratories Expects More M&A After Latest Deal Closes

Impax Laboratories Expects More M&A After Latest Deal Closes

Chief executive says the pharma company is hunting for its next deal after its $700 million Tower buy.

Impax Laboratories (IPXL) Strong On High Relative Volume Today

Impax Laboratories (IPXL) Strong On High Relative Volume Today

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a strong on high relative volume candidate

Impax Laboratories (IPXL) Reaches New Lifetime High Today

Impax Laboratories (IPXL) Reaches New Lifetime High Today

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a new lifetime high candidate

Today's Strong And Under The Radar Stock: Impax Laboratories (IPXL)

Today's Strong And Under The Radar Stock: Impax Laboratories (IPXL)

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a strong and under the radar candidate

First Week of January 2015 Options Trading For Impax Laboratories (IPXL)

First Week of January 2015 Options Trading For Impax Laboratories (IPXL)

Investors in Impax Laboratories Inc saw new options become available this week, for the January 2015 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IPXL options chain for the new January 2015 contracts and identified one put and one call contract of particular interest.

New Lifetime High For Impax Laboratories (IPXL)

New Lifetime High For Impax Laboratories (IPXL)

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a new lifetime high candidate

3 Stocks Spiking on Unusual Volume

3 Stocks Spiking on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Why Impax Laboratories (IPXL) Stock Is Spiking Today

Why Impax Laboratories (IPXL) Stock Is Spiking Today

Impax Laboratories (IPXL) shares are up double digits after the company purchased two pharmaceutical companies for $700 million.

Strong On High Volume: Impax Laboratories (IPXL)

Strong On High Volume: Impax Laboratories (IPXL)

Trade-Ideas LLC identified Impax Laboratories (IPXL) as a strong on high relative volume candidate

Lieff Cabraser Reminds Impax Laboratories, Inc. Investors Of Upcoming Deadline In Class Action Litigation – IPXL

Lieff Cabraser Reminds Impax Laboratories, Inc. Investors Of Upcoming Deadline In Class Action Litigation – IPXL

Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the October 13, 2014 deadline to move for appointment as lead plaintiff in the securities class litigation brought on behalf of those who purchased or ...

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors Of Class Action Against Impax Laboratories, Inc. And Its Board Of Directors And A Lead Plaintiff Deadline Of October 13, 2014

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors Of Class Action Against Impax Laboratories, Inc. And Its Board Of Directors And A Lead Plaintiff Deadline Of October 13, 2014

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Impax Laboratories, Inc.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Impax Laboratories Inc. To Contact Brower Piven Before The October 13, 2014 Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Impax Laboratories Inc. To Contact Brower Piven Before The October 13, 2014 Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

Interesting IPXL Put And Call Options For November 22nd

Interesting IPXL Put And Call Options For November 22nd

Investors in Impax Laboratories Inc saw new options become available this week, for the November 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IPXL options chain for the new November 22nd contracts and identified one put and one call contract of particular interest.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Impax Laboratories Inc. To Contact Brower Piven Before The October 13, 2014 Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Impax Laboratories Inc. To Contact Brower Piven Before The October 13, 2014 Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

SHAREHOLDER ALERT: Investigation On Behalf Of Impax Laboratories, Inc. Investors Announced By Law Offices Of Howard G. Smith

SHAREHOLDER ALERT: Investigation On Behalf Of Impax Laboratories, Inc. Investors Announced By Law Offices Of Howard G. Smith

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Impax Laboratories, Inc.

Impax Laboratories Inc Stock Upgraded (IPXL)

Impax Laboratories Inc Stock Upgraded (IPXL)

Impax Laboratories (Nasdaq:IPXL) has been upgraded by TheStreet Ratings from a hold to buy.